Suvretta Capital Management, LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
100
Total Value
2694889925
Accession Number
0001172661-25-002306
Form Type
13F-HR
Manager Name
Suvretta Capital Management, LLC
Data Enrichment
97% identified
97 identified3 unidentified

Holdings

100 positions
Manager:
Search and click to pin securities to the top
Zura Bio Ltd
Shares:
4860939(+0.0%)
Value:
$6.3B(-48.4%)
BioAge Labs, Inc.
Shares:
1452336(+0.0%)
Value:
$5.5B(-35.1%)
SUTRO BIOPHARMA, INC.
Shares:
7462495(+0.0%)
Value:
$4.9B(-64.6%)
Shares:
83701(-36.3%)
Value:
$4.6B(-26.8%)
EXACT SCIENCES CORP
Shares:
94100(+0.0%)
Value:
$4.1B(-22.9%)
Disc Medicine, Inc.
Shares:
80000
Value:
$4.0B
THERMO FISHER SCIENTIFIC INC.
Shares:
7900(+0.0%)
Value:
$3.9B(-4.3%)
Kezar Life Sciences, Inc.
Shares:
716759(+0.0%)
Value:
$3.5B(-27.4%)
03073E105
Shares:
12488(+0.0%)
Value:
$3.5B(+23.8%)
DANAHER CORP /DE/
Shares:
13600(+0.0%)
Value:
$2.8B(-10.7%)
Elanco Animal Health Inc
Shares:
253600(+0.0%)
Value:
$2.7B(-13.3%)
INTUITIVE SURGICAL INC
Shares:
5200(+0.0%)
Value:
$2.6B(-5.1%)
ALNYLAM PHARMACEUTICALS, INC.
Shares:
9370
Value:
$2.5B
002942100
Shares:
312500
Value:
$2.3B
PepGen Inc.
Shares:
1660932(+41.4%)
Value:
$2.3B(-47.6%)
METTLER TOLEDO INTERNATIONAL INC/
Shares:
1964(+0.0%)
Value:
$2.3B(-3.5%)
Medtronic plc
Shares:
25060(+43.5%)
Value:
$2.3B(+61.5%)
STRYKER CORP
Shares:
5860(+34.4%)
Value:
$2.2B(+39.0%)
DEXCOM INC
Shares:
31680(+0.0%)
Value:
$2.2B(-12.2%)
Trevi Therapeutics, Inc.
Shares:
340164
Value:
$2.1B